病毒性肝病患者生化检验指标的诊断效果研究(1)
[摘要] 目的 分析研究病毒性肝病患者生化檢验指标的诊断效果。方法 以2015年3月—2017年1月为时间段，方便选取该院收治的100例病毒性肝病患者，设置为研究组，选取到该院参与体检的100名健康者，设置为对照组，检测所有对象生化指标，并对比分析检测结果。 结果 在淋巴细胞、白细胞、血小板以及中性粒细胞检查方面，研究组分别是(36.7±10.39)%、(5.1±1.75)×109/L、(114.5±68.42)×109/L以及(53.9±11.27)%，对照组分别是(28.4±6.47)%、(6.9±1.32)×109/L、(175.3±73.41)×109/L以及(62.8±8.69)%，研究组淋巴细胞水平高于对照组(P<0.05)，研究组白细胞、血小板以及中性粒细胞水平显著低于对照组(P<0.05)。在ALT、TBIL、ALB以及A/G指标方面，研究组分别是(84.2±34.81)U/L、(25.3±13.28)mmol/L、(37.5±5.87)g/L以及(1.1±0.19)，对照组分别是(29.4±19.74)U/L、(14.5±8.64)mmol/L、(46.9±6.03)g/L以及(1.6±0.32)，研究组ALT、TBIL显著高于对照组，而ALB、A/G显著低于对照组，差异有统计学意义(P<0.05)；在CHE、PA、ADA以及AFU指标方面，对照组分别是(2.8±0.31)kU/L、(0.4±0.53)mmol/L、(35.2±13.28)U/L以及(35.7±4.75)U/L，研究组分别是(6.5±2.53)kU/L、(0.2±0.06)mmol/L、(23.6±6.39)U/L以及(40.3±5.97)U/L，两组对象的CHE、PA、ADA、AFU水平差异有统计学意义(P<0.05)。结论 生化检验指标对病毒性肝病患者临床诊断具有较高的应用价值，值得广泛推广。
[关键词] 病毒性肝病；生化检验指标；诊断效果
[中图分类号] R512.6；R446.1 [文献标识码] A [文章编号] 1674-0742(2018)07(a)-0004-04
Study on the Diagnostic Effect of Biochemical Test Indicators in Patients with Viral Liver Disease
LI Bin-bing
Deyang Fifth Hospital， Deyang， Sichuan Province， 618000 China
[Abstract] Objective This paper tries to analyze the diagnostic effect of biochemical test index for patients with viral liver disease. Methods For the period from March 2015 to January 2017， 100 patients with viral liver diseases admitted to the hospital were selected conveniently as study groups. 100 healthy people who participated in the physical examination were selected as the control group and object biochemical indicators all were tested， and test results were comparatively analyzed. Results In lymphocyte， leukocyte， platelet， and neutrophil examinations， the study group was (36.7±10.39)%， (5.1±1.75)×109/L， (114.5±68.42)×109/L， and (53.9±11.27)%， respectively， and the control group was (28.4±6.47)%， (6.9±1.32)×109/L， (175.3±73.41)×109/L， and (62.8±8.69)% lymphocytes in the study group were higher than those in the control group (P<0.05). The leukocyte， platelet， and neutrophils levels were significantly lower in the study group than the control group (P<0.05). The ALT， TBIL， ALB， and A/G indices were (84.2±34.81)U/L， (25.3±13.28)mmol/L， (37.5±5.87)g/L， and (1.1±0.19) in the study group， and (29.4±19.74)U/L in the control group， respectively， (14.5±8.64)mmol/L， (46.9±6.03)g/L， and (1.6±0.32). ALT and TBIL in the study group were significantly higher than those in the control group， while ALB and A/G were significantly lower than those in the control group. The difference was statistically significant (P<0.05)； In CHE， PA， ADA and AFU indicators， the control group was (2.8±0.31)kU/L， (0.4±0.53)mmol/L， (35.2±13.28)U/L， and (35.7±4.75)U/L， respectively， the study group was (6.5±2.53)kU/L，(0.2±0.06)mmol/L，(23.6±6.39)U/L， and(40.3±5.97)U/L， There were statistically significant difference in CHE， PA， ADA， and AFU levels between the two groups (P<0.05). Conclusion In patients with viral liver disease， biochemical test indicators have a high application value for clinical diagnosis and are worthy of widespread promotion., 百拇医药(李彬兵)
[关键词] 病毒性肝病；生化检验指标；诊断效果
[中图分类号] R512.6；R446.1 [文献标识码] A [文章编号] 1674-0742(2018)07(a)-0004-04
Study on the Diagnostic Effect of Biochemical Test Indicators in Patients with Viral Liver Disease
LI Bin-bing
Deyang Fifth Hospital， Deyang， Sichuan Province， 618000 China
[Abstract] Objective This paper tries to analyze the diagnostic effect of biochemical test index for patients with viral liver disease. Methods For the period from March 2015 to January 2017， 100 patients with viral liver diseases admitted to the hospital were selected conveniently as study groups. 100 healthy people who participated in the physical examination were selected as the control group and object biochemical indicators all were tested， and test results were comparatively analyzed. Results In lymphocyte， leukocyte， platelet， and neutrophil examinations， the study group was (36.7±10.39)%， (5.1±1.75)×109/L， (114.5±68.42)×109/L， and (53.9±11.27)%， respectively， and the control group was (28.4±6.47)%， (6.9±1.32)×109/L， (175.3±73.41)×109/L， and (62.8±8.69)% lymphocytes in the study group were higher than those in the control group (P<0.05). The leukocyte， platelet， and neutrophils levels were significantly lower in the study group than the control group (P<0.05). The ALT， TBIL， ALB， and A/G indices were (84.2±34.81)U/L， (25.3±13.28)mmol/L， (37.5±5.87)g/L， and (1.1±0.19) in the study group， and (29.4±19.74)U/L in the control group， respectively， (14.5±8.64)mmol/L， (46.9±6.03)g/L， and (1.6±0.32). ALT and TBIL in the study group were significantly higher than those in the control group， while ALB and A/G were significantly lower than those in the control group. The difference was statistically significant (P<0.05)； In CHE， PA， ADA and AFU indicators， the control group was (2.8±0.31)kU/L， (0.4±0.53)mmol/L， (35.2±13.28)U/L， and (35.7±4.75)U/L， respectively， the study group was (6.5±2.53)kU/L，(0.2±0.06)mmol/L，(23.6±6.39)U/L， and(40.3±5.97)U/L， There were statistically significant difference in CHE， PA， ADA， and AFU levels between the two groups (P<0.05). Conclusion In patients with viral liver disease， biochemical test indicators have a high application value for clinical diagnosis and are worthy of widespread promotion., 百拇医药(李彬兵)